High level of EPA is associated with lower perivascular coronary attenuation as measured by coronary CTA
SESSION Poster Session 7
SPEAKER Daniel Bittner
Congress : ESC Congress 2019
Topic : Imaging
Sub-topic : Coronary CT Angiography
Session type : Poster Session
FP Number : P6164
Authors : D O Bittner (Erlangen,DE), M Goeller (Erlangen,DE), Y Zopf (Erlangen,DE), S Achenbach (Erlangen,DE), M Marwan (Erlangen,DE)
D O Bittner1 , M Goeller1 , Y Zopf1 , S Achenbach1 , M Marwan1 , 1University of Erlangen-Nuremberg (Friedrich-Alexander-University) - Erlangen - Germany ,
Citation:
Introduction: Pericoronary adipose tissue (PCAT) composition has been recently shown to be a potential novel marker of coronary inflammation with higher PCAT attenuation shown to indicate increased cardiac mortality. Polyunsaturated fatty acids (PUFAs), especially Omega-3 fatty acids (n3), are thought to alter inflammatory response and intake of high dose Eicosapentaenoic acid (EPA, C20_5 n3) was shown to decrease mortality, however exact pathophysiological mechanisms are unclear. Therefore, we sought to determine whether blood levels of PUFAs are associated with differences in pericoronary fat attenuation.
Methods: In 64 symptomatic patients with intermediate pretest-likelihood for coronary artery disease presenting with atypical angina, coronary CTA was performed. PCAT attenuation was measured in Hounsfield Units (HU) around the proximal 40mm of the right coronary artery (RCA) using semi-automated software. Erythrocyte membrane fatty acid composition (in percentage) was analyzed with a standardized analytical methodology, displaying a variety of fatty acids including n-3 fatty acids using gas chromatography.
Results: Patients were divided into two groups (each n=32) using the median PCAT attenuation of -78.1 Hounsfield units (HU), resulting in one group with low (-95.58 to -78.17 HU) and one with high (-78.06 to -62.92 HU) PCAT attenuation. Among both groups, no differences were seen in age, sex, BMI, traditional cardiovascular risk factors or the number of cardiovascular risk factors (all p>0.05). In univariate analysis, significantly higher values of EPA (1.00% [0.78; 1.26] vs. 0.78 % [0.63; 0.99]; p=0.02) were seen in patients with lower PCAT attenuation. All other fatty acids showed no significant differences (all p >0.05). Moreover, a significant negative correlation was seen between PCAT attenuation and EPA (Pearson correlation coefficient -0.38; p=0.002), but not for age, sex, BMI or number of cardiovascular risk factors (all p>0.1). Multivariable linear regression analysis confirmed this association and showed a significant inverse association of EPA to PCAT attenuation (ß=-0.31, p=0.017), independent of age, gender, BMI and number of CV risk factors (all p>0.1).
Conclusion: High levels of EPA are associated with lower PCAT attenuation on coronary CTA indicating different composition of pericoronary adipose tissue potentially caused by a lesser degree of coronary inflammation.
